Down Syndrome and Malignancies: A Unique Clinical Relationship

This publication has 88 references indexed in Scilit:

• Trisomy 21 enhances human fetal erythro-megakaryocytic development
  Blood, 2008
• Congenital Abnormalities and Acute Leukemia among Children with Down Syndrome: A Children's Oncology Group Study
  Cancer Epidemiology, Biomarkers & Prevention, 2008
• Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with down syndrome
  Pediatric Blood & Cancer, 2008
• Treatment and prognostic impact of transient leukemia in neonates with Down syndrome
  Blood, 2008
• Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study
  Blood, 2008
• Risk of Death for Children with Down Syndrome and Sepsis
  The Journal of Pediatrics, 2005
• Immunology of Down syndrome: A review
  American Journal of Medical Genetics, 2005
• GATA1 in normal and malignant hematopoiesis
  Seminars in Cell & Developmental Biology, 2005
• Vascular Endothelial Growth Factor- and Thrombin-induced Termination Factor, Down Syndrome Critical Region-1, Attenuates Endothelial Cell Proliferation and Angiogenesis
  Journal of Biological Chemistry, 2004
• Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952
  Pediatric Blood & Cancer, 2004